Os efeitos so percebidos em 4/6 semanas aps a primeira sesso com resultado final aps 3 meses
They're designed to: Confirm the weight loss and metabolic benefits seen in Phase 2 Identify rare side effects that smaller trials might have missed Demonstrate consistent results across diverse populations (age, sex, ethnicity, comorbidities) Build long-term safety data (cardiovascular outcomes, liver health, kidney function) Provide the evidence package the FDA needs to approve the drug Retatrutide's Phase 2 results were strong enough (up to 24.2% weight loss) that Eli Lilly moved it into a large Phase 3 program
: - 5.90
But you have to get over the initial hump, and thats where having a care team that knows what to expect really matters. Patients who get a prescription without ongoing support are far more likely to quit before their body has adjusted, he added
Bauer, director of research at the Mayo Clinic section of Integrative Medicine, in an interview with Mayo Clinic Press
Axonal transport deficits and neurodegenerative diseases
